Table 2.
Outcome | DAS28 β (95% CI)†‡ | SJC β (95% CI)§ | TJC β (95% CI)§ | PGA β (95% CI)§ | ESR β (95% CI)§ | |
Male (n=52) | Female (n=122) | |||||
RAPID3* (0–10) | 0.29 (0.24 to 0.35) | 0.29 (0.17 to 0.41) | 0.89 (0.61 to 1.17) | 0.94 (0.84 to 1.04) | 0.37 (0.08 to 0.67) | −0.03 (−0.47 to 0.41) |
Statistically significant results are shown in bold.
*RAPID3 domains: functioning, pain and PGA.
†DAS28 (four variables, ESR-based).
‡Models derived from 207 patients.
§Models derived from 172 patients.
DAS28, Disease Activity Score in 28 joints; DAS28-ESR, Disease Activity Score in 28 joints that includes the erythrocyte sedimentation rate; ESR, erythrocyte sedimentation rate; PGA, patient global assessment; RAPID3, Routine Assessment of Patient Index Data 3; SJC, swollen joint count; TJC, tender joint count.